MC-30

N/A

Report date: 2023/01/07 14:29:51
NME

Base Information

Drug NameMC-30
Drug Alias NameMC-30
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionInsulin-like growth factor I receptor antagonistsRNA interferenceHepatocyte growth factor receptor inhibitors +[4] 
TargetsEpidermal growth factor receptor erbB1Insulin-like growth factor I receptorHepatocyte growth factor receptor
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMiRecule Inc
China Registration ClassN/A

Develop Information

Active CompaniesMiRecule Inc
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A